Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations

[Display omitted] The present work reports the development, optimization and characterization of novel lipid based nanoformulations viz., Liquid crystalline nanoparticles (LCNP), solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) and liposomes loaded with Tacrolimus (Tac) for to...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics 2019-05, Vol.562, p.96-104
Main Authors: Jain, Sanyog, Addan, Ramu, Kushwah, Varun, Harde, Harshad, Mahajan, Rahul R.
Format: Article
Language:English
Subjects:
Drug entrapment
LCNP
Liposomes
NLC
SLN
Tacrolimus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c365t-967c8c047955a49d6500b104d67f64ec6ad785615ac8736d9a099e0ba39992563
cites cdi_FETCH-LOGICAL-c365t-967c8c047955a49d6500b104d67f64ec6ad785615ac8736d9a099e0ba39992563
container_end_page 104
container_issue
container_start_page 96
container_title International journal of pharmaceutics
container_volume 562
creator Jain, Sanyog
Addan, Ramu
Kushwah, Varun
Harde, Harshad
Mahajan, Rahul R.
description [Display omitted] The present work reports the development, optimization and characterization of novel lipid based nanoformulations viz., Liquid crystalline nanoparticles (LCNP), solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) and liposomes loaded with Tacrolimus (Tac) for topical delivery. Different nanoformulations were developed after screening lipids and suitable surfactants depending upon emulsification ability. The various nanoformulations were then optimized (to achieve higher entrapment efficacy, lower particle size, PDI and zeta potential), characterized and loaded into gel. The gels loaded with nanoformulations were also characterized depending upon rheology and viscosity. The gels were analyzed for in vitro drug release, HaCaT cell lines studies and skin permeation studies. The in vivo efficacy studies were carried out using mouse tail model and skin irritation studies using Draize patch test and measurement of TEWL. The developed nanoformulations showed optimum particle size (
doi_str_mv 10.1016/j.ijpharm.2019.03.042
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2196531671</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517319302285</els_id><sourcerecordid>2196531671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-967c8c047955a49d6500b104d67f64ec6ad785615ac8736d9a099e0ba39992563</originalsourceid><addsrcrecordid>eNqFkEGP0zAQhS0EYrsLPwGUI5eEcRzb9QmhCliklbgsZ2tqj4WrJA52Wqn_HlctXDmNNPPevJmPsXccOg5cfTx08bD8wjx1PXDTgehg6F-wDd9q0YpBq5dsA0JvW8m1uGP3pRwAQPVcvGZ3Agz0GtSGnXZpWjDjGk_UYClUykTz2qTQUAjRoTs3OPumYKD13CxprdOI40UwHcc1BswxHUszxiX6Zo-FfPOMLqcxTpd2Ql87M84ppFwdNSnN5Q17FXAs9PZWH9jPr1-ed4_t049v33efn1onlFxbo7TbOhi0kRIH45UE2HMYvNJBDeQUer2Vikt09W3lDYIxBHsUxpheKvHAPlz3Ljn9PlJZ7RSLo3HEmerVtudGScGV5lUqr9J6eymZgl1ynDCfLQd7QW4P9obcXpBbELYir773t4jjfiL_z_WXcRV8ugqoPnqKlG1xkWZHPmZyq_Up_ifiD7uclwg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2196531671</pqid></control><display><type>article</type><title>Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations</title><source>Elsevier</source><creator>Jain, Sanyog ; Addan, Ramu ; Kushwah, Varun ; Harde, Harshad ; Mahajan, Rahul R.</creator><creatorcontrib>Jain, Sanyog ; Addan, Ramu ; Kushwah, Varun ; Harde, Harshad ; Mahajan, Rahul R.</creatorcontrib><description>[Display omitted] The present work reports the development, optimization and characterization of novel lipid based nanoformulations viz., Liquid crystalline nanoparticles (LCNP), solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) and liposomes loaded with Tacrolimus (Tac) for topical delivery. Different nanoformulations were developed after screening lipids and suitable surfactants depending upon emulsification ability. The various nanoformulations were then optimized (to achieve higher entrapment efficacy, lower particle size, PDI and zeta potential), characterized and loaded into gel. The gels loaded with nanoformulations were also characterized depending upon rheology and viscosity. The gels were analyzed for in vitro drug release, HaCaT cell lines studies and skin permeation studies. The in vivo efficacy studies were carried out using mouse tail model and skin irritation studies using Draize patch test and measurement of TEWL. The developed nanoformulations showed optimum particle size (&lt;200 nm), polydispersity index (PDI &lt; 0.3), zeta potential (≥−10 mV) and higher entrapment efficiency (&gt;85%). The nanoformulations showed higher penetration of Tac into skin. Tac-LCNP, Tac-SLN, Tac-NLC and Tac-liposomes loaded gels showed 14, 11.5, 12.5 and 3.7 folds increment in dermal bioavailability respectively, in comparison to free Tac loaded gel and 2.5, 2 and ∼2 folds augmentation in dermal bioavailability respectively as compared to Tacroz™ Forte. In case of Tac-liposomes, the dermal bioavailability was lower as compared with the marketed formulation, Tacroz™ Forte. Despite, the increased bioavailability into the skin, the developed nanoformulations showed no significant skin irritation. The above mentioned nanoformulations were able to achieve greater penetration of Tac into the skin as compared to marketed ointment of Tac, Tacroz™ Forte.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2019.03.042</identifier><identifier>PMID: 30902706</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Drug entrapment ; LCNP ; Liposomes ; NLC ; SLN ; Tacrolimus</subject><ispartof>International journal of pharmaceutics, 2019-05, Vol.562, p.96-104</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-967c8c047955a49d6500b104d67f64ec6ad785615ac8736d9a099e0ba39992563</citedby><cites>FETCH-LOGICAL-c365t-967c8c047955a49d6500b104d67f64ec6ad785615ac8736d9a099e0ba39992563</cites><orcidid>0000-0002-0636-6674</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30902706$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jain, Sanyog</creatorcontrib><creatorcontrib>Addan, Ramu</creatorcontrib><creatorcontrib>Kushwah, Varun</creatorcontrib><creatorcontrib>Harde, Harshad</creatorcontrib><creatorcontrib>Mahajan, Rahul R.</creatorcontrib><title>Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>[Display omitted] The present work reports the development, optimization and characterization of novel lipid based nanoformulations viz., Liquid crystalline nanoparticles (LCNP), solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) and liposomes loaded with Tacrolimus (Tac) for topical delivery. Different nanoformulations were developed after screening lipids and suitable surfactants depending upon emulsification ability. The various nanoformulations were then optimized (to achieve higher entrapment efficacy, lower particle size, PDI and zeta potential), characterized and loaded into gel. The gels loaded with nanoformulations were also characterized depending upon rheology and viscosity. The gels were analyzed for in vitro drug release, HaCaT cell lines studies and skin permeation studies. The in vivo efficacy studies were carried out using mouse tail model and skin irritation studies using Draize patch test and measurement of TEWL. The developed nanoformulations showed optimum particle size (&lt;200 nm), polydispersity index (PDI &lt; 0.3), zeta potential (≥−10 mV) and higher entrapment efficiency (&gt;85%). The nanoformulations showed higher penetration of Tac into skin. Tac-LCNP, Tac-SLN, Tac-NLC and Tac-liposomes loaded gels showed 14, 11.5, 12.5 and 3.7 folds increment in dermal bioavailability respectively, in comparison to free Tac loaded gel and 2.5, 2 and ∼2 folds augmentation in dermal bioavailability respectively as compared to Tacroz™ Forte. In case of Tac-liposomes, the dermal bioavailability was lower as compared with the marketed formulation, Tacroz™ Forte. Despite, the increased bioavailability into the skin, the developed nanoformulations showed no significant skin irritation. The above mentioned nanoformulations were able to achieve greater penetration of Tac into the skin as compared to marketed ointment of Tac, Tacroz™ Forte.</description><subject>Drug entrapment</subject><subject>LCNP</subject><subject>Liposomes</subject><subject>NLC</subject><subject>SLN</subject><subject>Tacrolimus</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkEGP0zAQhS0EYrsLPwGUI5eEcRzb9QmhCliklbgsZ2tqj4WrJA52Wqn_HlctXDmNNPPevJmPsXccOg5cfTx08bD8wjx1PXDTgehg6F-wDd9q0YpBq5dsA0JvW8m1uGP3pRwAQPVcvGZ3Agz0GtSGnXZpWjDjGk_UYClUykTz2qTQUAjRoTs3OPumYKD13CxprdOI40UwHcc1BswxHUszxiX6Zo-FfPOMLqcxTpd2Ql87M84ppFwdNSnN5Q17FXAs9PZWH9jPr1-ed4_t049v33efn1onlFxbo7TbOhi0kRIH45UE2HMYvNJBDeQUer2Vikt09W3lDYIxBHsUxpheKvHAPlz3Ljn9PlJZ7RSLo3HEmerVtudGScGV5lUqr9J6eymZgl1ynDCfLQd7QW4P9obcXpBbELYir773t4jjfiL_z_WXcRV8ugqoPnqKlG1xkWZHPmZyq_Up_ifiD7uclwg</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Jain, Sanyog</creator><creator>Addan, Ramu</creator><creator>Kushwah, Varun</creator><creator>Harde, Harshad</creator><creator>Mahajan, Rahul R.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0636-6674</orcidid></search><sort><creationdate>20190501</creationdate><title>Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations</title><author>Jain, Sanyog ; Addan, Ramu ; Kushwah, Varun ; Harde, Harshad ; Mahajan, Rahul R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-967c8c047955a49d6500b104d67f64ec6ad785615ac8736d9a099e0ba39992563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Drug entrapment</topic><topic>LCNP</topic><topic>Liposomes</topic><topic>NLC</topic><topic>SLN</topic><topic>Tacrolimus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jain, Sanyog</creatorcontrib><creatorcontrib>Addan, Ramu</creatorcontrib><creatorcontrib>Kushwah, Varun</creatorcontrib><creatorcontrib>Harde, Harshad</creatorcontrib><creatorcontrib>Mahajan, Rahul R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jain, Sanyog</au><au>Addan, Ramu</au><au>Kushwah, Varun</au><au>Harde, Harshad</au><au>Mahajan, Rahul R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>562</volume><spage>96</spage><epage>104</epage><pages>96-104</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted] The present work reports the development, optimization and characterization of novel lipid based nanoformulations viz., Liquid crystalline nanoparticles (LCNP), solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) and liposomes loaded with Tacrolimus (Tac) for topical delivery. Different nanoformulations were developed after screening lipids and suitable surfactants depending upon emulsification ability. The various nanoformulations were then optimized (to achieve higher entrapment efficacy, lower particle size, PDI and zeta potential), characterized and loaded into gel. The gels loaded with nanoformulations were also characterized depending upon rheology and viscosity. The gels were analyzed for in vitro drug release, HaCaT cell lines studies and skin permeation studies. The in vivo efficacy studies were carried out using mouse tail model and skin irritation studies using Draize patch test and measurement of TEWL. The developed nanoformulations showed optimum particle size (&lt;200 nm), polydispersity index (PDI &lt; 0.3), zeta potential (≥−10 mV) and higher entrapment efficiency (&gt;85%). The nanoformulations showed higher penetration of Tac into skin. Tac-LCNP, Tac-SLN, Tac-NLC and Tac-liposomes loaded gels showed 14, 11.5, 12.5 and 3.7 folds increment in dermal bioavailability respectively, in comparison to free Tac loaded gel and 2.5, 2 and ∼2 folds augmentation in dermal bioavailability respectively as compared to Tacroz™ Forte. In case of Tac-liposomes, the dermal bioavailability was lower as compared with the marketed formulation, Tacroz™ Forte. Despite, the increased bioavailability into the skin, the developed nanoformulations showed no significant skin irritation. The above mentioned nanoformulations were able to achieve greater penetration of Tac into the skin as compared to marketed ointment of Tac, Tacroz™ Forte.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>30902706</pmid><doi>10.1016/j.ijpharm.2019.03.042</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0636-6674</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2019-05, Vol.562, p.96-104
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_2196531671
source Elsevier
subjects Drug entrapment
LCNP
Liposomes
NLC
SLN
Tacrolimus
title Comparative assessment of efficacy and safety potential of multifarious lipid based Tacrolimus loaded nanoformulations
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A44%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20assessment%20of%20efficacy%20and%20safety%20potential%20of%20multifarious%20lipid%20based%20Tacrolimus%20loaded%20nanoformulations&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Jain,%20Sanyog&rft.date=2019-05-01&rft.volume=562&rft.spage=96&rft.epage=104&rft.pages=96-104&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2019.03.042&rft_dat=%3Cproquest_cross%3E2196531671%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-967c8c047955a49d6500b104d67f64ec6ad785615ac8736d9a099e0ba39992563%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2196531671&rft_id=info:pmid/30902706&rfr_iscdi=true